Small fiber neuropathy, erythromelalgia, and central neuropathic pain syndromes are frequently misidentified neuropathic pain syndromes. This session focuses on the accurate diagnosis of these unique neuropathic pain syndromes, limitations of traditional neuropathic pain treatment algorithms in their successful management, and the role of non-traditional interventions in their management.
Unique Treatments for Small Fiber Neuropathy, Erythromelalgia, and Central Neuropathic Pain Syndromes
James C. Watson, MD
Small Fiber Neuropathy, Erythromelalgia, and Central Neuropathic Pain: Unique Treatments
Paola Sandroni, MD PhD
- Describe the diagnostic an evidence-based pharmacologic and interventional treatment approach to clinically suspected small fiber neuropathy.
- Recognize the clinical features of erythromelalgia and its unique treatment considerations.
- Review the unique mechanisms necessary to develop a central neuropathic pain state and how to differentiate a central neuropathic pain state from other pain types in a neurologically devastated patient.
- Review an evidence-based treatment approach for central neuropathic pain utilizing traditional neuropathic pain agents, cannabinoids, spinal cord stimulation, deep brain and motor cortex stimulation, and transcranial magnetic stimulation.
- Multidisciplinary Care Model and Contemporary Strategies for Intrathecal Drug Delivery (203)
- Ketamine for Pain, Depression, and Post-Traumatic Stress Disorder (PTSD): What Do We Know? (206)
- Neuropathic Pain: Beyond Adjuvants and Opioids: A Look at New and Reemerging Treatments (207)
- Collecting Patient-Reported Outcomes (PROs) to Enhance Your Practice and What the Collected Registry Data Tells Us So Far (210)
- Suicidality and Chronic Pain: Research/Risk Factors and Monitoring/Evaluation/Treatment in the Context of Opioid Tapering (211)